UPDATE 2-Catalent bolsters biopharma business with Cook Pharmica buy
September 19, 2017 at 11:37 AM EDT
Sept 19 (Reuters) - U.S. drug contract manufacturer Catalent Inc agreed to buy Cook Pharmica LLC for $950 million in cash as the company doubles down on its fast-growing business of supplying biologics to drugmakers.
